Skip to main content
Erschienen in: Virchows Archiv 5/2019

17.06.2019 | Brief Report

Pathologist second opinion significantly alters clinical management of pT1 endoscopically resected colorectal cancer

verfasst von: Gian Luca Rampioni Vinciguerra, Giulio Antonelli, Francesca Citron, Giammauro Berardi, Stefano Angeletti, Gustavo Baldassarre, Andrea Vecchione, Emilio Di Giulio, Emanuela Pilozzi

Erschienen in: Virchows Archiv | Ausgabe 5/2019

Einloggen, um Zugang zu erhalten

Abstract

We retrospectively collected a series of 82 endoscopically removed early colorectal cancers. Histological specimens were revised by two gastrointestinal pathologists, performing a re-evaluation of all risk factors for lymph node metastasis. The comparison between second opinion and first pathological report revealed that lymphovascular invasion and tumor grading showed a lower level of concordance than other parameters. Our results demonstrated that second opinion modified risk assessment in about 10% of cases. It was mainly due to a lack in reporting of some parameters at the first diagnosis and a different evaluation in second opinion for updated guidelines. Considering the subgroup of patients with modified risk assessment, clinical data revealed that tumors, re-classified as low risk, did not develop lymph node metastasis that, conversely, occurred in patients identified as high risk by second opinion. In conclusion, second opinion significantly alters risk perception of endoscopically removed early colorectal carcinomas representing a valuable tool for their appropriate clinical management.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Lopez A, Bouvier AM, Jooste V, Cottet V, Romain G, Faivre J, Manfredi S, Lepage C (2019) Outcomes following polypectomy for malignant colorectal polyps are similar to those following surgery in the general population. Gut. 68(1):111–117CrossRef Lopez A, Bouvier AM, Jooste V, Cottet V, Romain G, Faivre J, Manfredi S, Lepage C (2019) Outcomes following polypectomy for malignant colorectal polyps are similar to those following surgery in the general population. Gut. 68(1):111–117CrossRef
2.
Zurück zum Zitat Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR, Winchester DP (2017) The eighth edition AJCC Cancer staging manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin 67(2):93–99CrossRef Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR, Winchester DP (2017) The eighth edition AJCC Cancer staging manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin 67(2):93–99CrossRef
3.
Zurück zum Zitat Bosch SL, Teerenstra S, de Wilt JH, Cunningham C, Nagtegaal ID (2013) Predicting lymph node metastasis in pT1 colorectal cancer: a systematic review of risk factors providing rationale for therapy decisions. Endoscopy. 45(10):827–834CrossRef Bosch SL, Teerenstra S, de Wilt JH, Cunningham C, Nagtegaal ID (2013) Predicting lymph node metastasis in pT1 colorectal cancer: a systematic review of risk factors providing rationale for therapy decisions. Endoscopy. 45(10):827–834CrossRef
4.
Zurück zum Zitat Ueno H, Mochizuki H, Hashiguchi Y, Shimazaki H, Aida S, Hase K, Matsukuma S, Kanai T, Kurihara H, Ozawa K, Yoshimura K, Bekku S (2004) Risk factors for an adverse outcome in early invasive colorectal carcinoma. Gastroenterology. 127(2):385–394CrossRef Ueno H, Mochizuki H, Hashiguchi Y, Shimazaki H, Aida S, Hase K, Matsukuma S, Kanai T, Kurihara H, Ozawa K, Yoshimura K, Bekku S (2004) Risk factors for an adverse outcome in early invasive colorectal carcinoma. Gastroenterology. 127(2):385–394CrossRef
5.
Zurück zum Zitat Antonelli G, Berardi G, Rampioni Vinciguerra GL, Brescia A, Ruggeri M, Mercantini P, Corleto VD, D’Ambra G, Pilozzi E, Hassan C, Angeletti S, Di Giulio E (2018) Clinical management of endoscopically resected pT1 colorectal cancer. Endoscopy Int Open 6(12):E1462–E14E9CrossRef Antonelli G, Berardi G, Rampioni Vinciguerra GL, Brescia A, Ruggeri M, Mercantini P, Corleto VD, D’Ambra G, Pilozzi E, Hassan C, Angeletti S, Di Giulio E (2018) Clinical management of endoscopically resected pT1 colorectal cancer. Endoscopy Int Open 6(12):E1462–E14E9CrossRef
6.
Zurück zum Zitat Peck M, Moffat D, Latham B, Badrick T (2018) Review of diagnostic error in anatomical pathology and the role and value of second opinions in error prevention. J Clin Pathol 71(11):995–1000CrossRef Peck M, Moffat D, Latham B, Badrick T (2018) Review of diagnostic error in anatomical pathology and the role and value of second opinions in error prevention. J Clin Pathol 71(11):995–1000CrossRef
7.
Zurück zum Zitat Steele RJ, Pox C, Kuipers EJ, Minoli G, Lambert R (2012) International Agency for Research on Cancer. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First edition--management of lesions detected in colorectal cancer screening. Endoscopy. 44(Suppl 3):SE140–SE150PubMed Steele RJ, Pox C, Kuipers EJ, Minoli G, Lambert R (2012) International Agency for Research on Cancer. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First edition--management of lesions detected in colorectal cancer screening. Endoscopy. 44(Suppl 3):SE140–SE150PubMed
8.
Zurück zum Zitat Haggitt RC, Glotzbach RE, Soffer EE, Wruble LD (1985) Prognostic factors in colorectal carcinomas arising in adenomas: implications for lesions removed by endoscopic polypectomy. Gastroenterology. 89(2):328–336CrossRef Haggitt RC, Glotzbach RE, Soffer EE, Wruble LD (1985) Prognostic factors in colorectal carcinomas arising in adenomas: implications for lesions removed by endoscopic polypectomy. Gastroenterology. 89(2):328–336CrossRef
9.
Zurück zum Zitat Kikuchi R, Takano M, Takagi K, Fujimoto N, Nozaki R, Fujiyoshi T, Uchida Y (1995) Management of early invasive colorectal cancer. Risk of recurrence and clinical guidelines. Dis Colon Rectum 38(12):1286–1295CrossRef Kikuchi R, Takano M, Takagi K, Fujimoto N, Nozaki R, Fujiyoshi T, Uchida Y (1995) Management of early invasive colorectal cancer. Risk of recurrence and clinical guidelines. Dis Colon Rectum 38(12):1286–1295CrossRef
10.
Zurück zum Zitat Lugli A, Kirsch R, Ajioka Y, Bosman F, Cathomas G, Dawson H et al (2017) Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016. Modern pathology : an official journal of the United States and Canadian Academy of Pathology. Inc. 30(9):1299–1311 Lugli A, Kirsch R, Ajioka Y, Bosman F, Cathomas G, Dawson H et al (2017) Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016. Modern pathology : an official journal of the United States and Canadian Academy of Pathology. Inc. 30(9):1299–1311
11.
Zurück zum Zitat West NP, Langman G, Haboubi N, Carey F, Henry J, Morgan M, Sheahan K (2019) Significant polyps and early colorectal cancer: the importance of high-quality standardized histopathology. Color Dis : Off J Assoc Coloproctol G B Irel 21(Suppl 1):53–56CrossRef West NP, Langman G, Haboubi N, Carey F, Henry J, Morgan M, Sheahan K (2019) Significant polyps and early colorectal cancer: the importance of high-quality standardized histopathology. Color Dis : Off J Assoc Coloproctol G B Irel 21(Suppl 1):53–56CrossRef
12.
Zurück zum Zitat McHugh ML (2012) Interrater reliability: the kappa statistic. Biochem Med 22(3):276–282CrossRef McHugh ML (2012) Interrater reliability: the kappa statistic. Biochem Med 22(3):276–282CrossRef
13.
Zurück zum Zitat Labianca R, Nordlinger B, Beretta GD, Mosconi S, Mandala M, Cervantes A et al (2013) Early colon cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol : Off J Eur Soc Med Oncol 24(Suppl 6):vi64–vi72CrossRef Labianca R, Nordlinger B, Beretta GD, Mosconi S, Mandala M, Cervantes A et al (2013) Early colon cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol : Off J Eur Soc Med Oncol 24(Suppl 6):vi64–vi72CrossRef
14.
Zurück zum Zitat Hassan C, Pickhardt PJ, Di Giulio E, Hunink MG, Zullo A, Nardelli BB (2010) Value-of-information analysis to guide future research in the management of the colorectal malignant polyp. Dis Colon Rectum 53(2):135–142CrossRef Hassan C, Pickhardt PJ, Di Giulio E, Hunink MG, Zullo A, Nardelli BB (2010) Value-of-information analysis to guide future research in the management of the colorectal malignant polyp. Dis Colon Rectum 53(2):135–142CrossRef
Metadaten
Titel
Pathologist second opinion significantly alters clinical management of pT1 endoscopically resected colorectal cancer
verfasst von
Gian Luca Rampioni Vinciguerra
Giulio Antonelli
Francesca Citron
Giammauro Berardi
Stefano Angeletti
Gustavo Baldassarre
Andrea Vecchione
Emilio Di Giulio
Emanuela Pilozzi
Publikationsdatum
17.06.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Virchows Archiv / Ausgabe 5/2019
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-019-02603-y

Weitere Artikel der Ausgabe 5/2019

Virchows Archiv 5/2019 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …